The Telangana Drugs Control Administration (DCA) has issued an urgent 'stop use notice' for Almont-Kid Syrup, a children's medicine, after samples were found to be adulterated with toxic Ethylene Glycol (EG). This critical alert follows a laboratory report from the Central Drugs Standard Control Organisation (CDSCO), East Zone, Kolkata, which confirmed the presence of the highly toxic substance in the syrup. The affected product is identified as Almont-Kid Syrup, with Batch No. AL-24002, manufactured by Tridus Remedies located in Vaishali, Bihar. The syrup is commonly prescribed to children for treating symptoms of allergies, hay fever, and asthma. The DCA, under the authority of Director General Shahnawaz Qasim, has strongly advised the public to immediately cease using the syrup if they possess it and to report it to the nearest Drugs Control Authority without delay. Furthermore, all Drugs Inspectors and Assistant Directors across Telangana have been instructed to alert retailers, wholesalers, distributors, and hospitals to freeze any available stocks of the specified batch to ensure it is neither dispensed nor sold. The administration is actively monitoring the situation and has initiated necessary enforcement measures to prevent further risks to public health. Citizens can report possession of the product via a toll-free number operational during working hours. This move highlights the authorities' swift action to safeguard children's health following a potential contamination crisis. The incident underscores the ongoing vigilance required in drug quality control in India, especially concerning pediatric medications.